Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06073080 · ClinicalTrials.gov registry record · NA

Recovery Protein Nutrition as a Countermeasure for Anabolic Resistance Following Sleep Loss

A NA study, sponsored by United States Army Research Institute of Environmental Medicine.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT06073080 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06073080, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The current study will determine protein nutritional status (MPS and WBPB) in response to military-relevant sleep loss, and whether an even protein nutrition distribution during recovery optimally supports MPS and WBPB. Adults (n=20) will complete a 7d sleep satiated phase (\~7-9h target/d), a 4d military-relevant sleep restriction phase (\~4h /d), and a 3d recovery phase (\~7-9h target/d) in a randomized, parallel design. During recovery, volunteers will consume 1.6 g protein/kg/d as an even (\~0.4/0.4/0.4/0.4 g/kg) or skewed (\~0.11/0.27/1.15/0.07 g/kg) distribution. Sleep will be monitored throughout the study using wrist actigraphy and diaries. During each phase, integrated daily MPS will be estimated using ingested deuterium oxide, salivary and blood sampling, and muscle biopsies, while WBPB will be estimated using ingested 15-N alanine and urine collections. At the end of each phase, metabolic testing will be used to assess the effects of sleep loss on substrate utilization and include consuming a carbohydrate beverage, serial blood draws, indirect calorimetry, and steady-state aerobic exercise. The knowledge products derived from the proposed effort will be informative to next generation ration development and support military-specific recovery nutrition guidance following operations involving sleep loss.

Interventions

  • OTHER Protein Nutrition During Recovery

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-03-21
Est. Completion 2024-11-04
Phase NA

What the Registry Record Tells You About NCT06073080

The ClinicalTrials.gov registry entry for NCT06073080 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Protein Nutrition During Recovery is the first listed.

NCT06073080 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06073080 about?

NCT06073080 is a clinical study titled "Recovery Protein Nutrition as a Countermeasure for Anabolic Resistance Following Sleep Loss". The current study will determine protein nutritional status (MPS and WBPB) in response to military-relevant sleep loss, and whether an even protein nutrition distribution during recovery optimally supports MPS and WBPB. Adults (n=20) will complete a 7d sleep satiated phase (\~7-9h target/d), a 4d mi...

What is the current status of trial NCT06073080?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-21. Estimated completion is 2024-11-04.

What interventions are being tested in trial NCT06073080?

The interventions under investigation include: Protein Nutrition During Recovery (OTHER).

Who is sponsoring clinical trial NCT06073080?

This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.